nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PGD—Dacarbazine—melanoma	0.516	0.883	CbGbCtD
Meloxicam—PTGS2—melanoma	0.212	1	CbGaD
Meloxicam—CYP3A4—Temozolomide—melanoma	0.0394	0.0674	CbGbCtD
Meloxicam—CYP3A4—Vemurafenib—melanoma	0.0216	0.0369	CbGbCtD
Meloxicam—CYP3A4—Docetaxel—melanoma	0.00741	0.0127	CbGbCtD
Meloxicam—PTGS2—leg—melanoma	0.00129	0.101	CbGeAlD
Meloxicam—PTGS2—hindlimb—melanoma	0.00116	0.09	CbGeAlD
Meloxicam—PTGS2—appendage—melanoma	0.000991	0.0772	CbGeAlD
Meloxicam—PGD—neck—melanoma	0.000986	0.0768	CbGeAlD
Meloxicam—PTGS2—skin epidermis—melanoma	0.000824	0.0642	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—melanoma	0.000819	0.341	CrCbGaD
Meloxicam—PGD—eye—melanoma	0.000733	0.0571	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—melanoma	0.00073	0.304	CrCbGaD
Meloxicam—PGD—retina—melanoma	0.000727	0.0566	CbGeAlD
Meloxicam—PGD—skin of body—melanoma	0.000638	0.0497	CbGeAlD
Meloxicam—PTGS1—endothelium—melanoma	0.000626	0.0487	CbGeAlD
Meloxicam—PTGS2—endothelium—melanoma	0.000598	0.0466	CbGeAlD
Meloxicam—PGD—mammalian vulva—melanoma	0.000582	0.0453	CbGeAlD
Meloxicam—PTGS1—blood vessel—melanoma	0.000577	0.045	CbGeAlD
Meloxicam—PTGS2—blood vessel—melanoma	0.000552	0.043	CbGeAlD
Meloxicam—Piroxicam—PTGS2—melanoma	0.000451	0.188	CrCbGaD
Meloxicam—PGD—head—melanoma	0.000416	0.0324	CbGeAlD
Meloxicam—Piroxicam—ALB—melanoma	0.000402	0.167	CrCbGaD
Meloxicam—ABCC4—head—melanoma	0.000296	0.0231	CbGeAlD
Meloxicam—PGD—lymph node—melanoma	0.000291	0.0227	CbGeAlD
Meloxicam—PTGS1—skin of body—melanoma	0.000267	0.0208	CbGeAlD
Meloxicam—Dizziness—Vemurafenib—melanoma	0.000262	0.00205	CcSEcCtD
Meloxicam—Alopecia—Carmustine—melanoma	0.00026	0.00204	CcSEcCtD
Meloxicam—Angiopathy—Temozolomide—melanoma	0.000258	0.00203	CcSEcCtD
Meloxicam—Mental disorder—Carmustine—melanoma	0.000258	0.00203	CcSEcCtD
Meloxicam—Immune system disorder—Temozolomide—melanoma	0.000257	0.00202	CcSEcCtD
Meloxicam—Mediastinal disorder—Temozolomide—melanoma	0.000257	0.00201	CcSEcCtD
Meloxicam—Malnutrition—Carmustine—melanoma	0.000257	0.00201	CcSEcCtD
Meloxicam—Erythema—Carmustine—melanoma	0.000257	0.00201	CcSEcCtD
Meloxicam—Cough—Bleomycin—melanoma	0.000256	0.00201	CcSEcCtD
Meloxicam—PTGS2—skin of body—melanoma	0.000255	0.0199	CbGeAlD
Meloxicam—Dehydration—Docetaxel—melanoma	0.000255	0.002	CcSEcCtD
Meloxicam—Ill-defined disorder—Dactinomycin—melanoma	0.000254	0.002	CcSEcCtD
Meloxicam—Anaemia—Dactinomycin—melanoma	0.000253	0.00199	CcSEcCtD
Meloxicam—Liver function test abnormal—Docetaxel—melanoma	0.000253	0.00198	CcSEcCtD
Meloxicam—Vomiting—Vemurafenib—melanoma	0.000252	0.00197	CcSEcCtD
Meloxicam—Alopecia—Temozolomide—melanoma	0.000252	0.00197	CcSEcCtD
Meloxicam—Myalgia—Bleomycin—melanoma	0.00025	0.00196	CcSEcCtD
Meloxicam—Abdominal pain upper—Docetaxel—melanoma	0.00025	0.00196	CcSEcCtD
Meloxicam—Rash—Vemurafenib—melanoma	0.00025	0.00196	CcSEcCtD
Meloxicam—Mental disorder—Temozolomide—melanoma	0.000249	0.00196	CcSEcCtD
Meloxicam—Dermatitis—Vemurafenib—melanoma	0.000249	0.00196	CcSEcCtD
Meloxicam—Back pain—Carmustine—melanoma	0.000248	0.00195	CcSEcCtD
Meloxicam—Headache—Vemurafenib—melanoma	0.000248	0.00195	CcSEcCtD
Meloxicam—Erythema—Temozolomide—melanoma	0.000248	0.00195	CcSEcCtD
Meloxicam—Malnutrition—Temozolomide—melanoma	0.000248	0.00195	CcSEcCtD
Meloxicam—Discomfort—Bleomycin—melanoma	0.000247	0.00194	CcSEcCtD
Meloxicam—Malaise—Dactinomycin—melanoma	0.000247	0.00194	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000247	0.00193	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000247	0.00193	CcSEcCtD
Meloxicam—Leukopenia—Dactinomycin—melanoma	0.000245	0.00193	CcSEcCtD
Meloxicam—Nasopharyngitis—Docetaxel—melanoma	0.000245	0.00192	CcSEcCtD
Meloxicam—PTGS1—mammalian vulva—melanoma	0.000244	0.019	CbGeAlD
Meloxicam—Dysgeusia—Temozolomide—melanoma	0.000243	0.0019	CcSEcCtD
Meloxicam—Confusional state—Bleomycin—melanoma	0.000242	0.0019	CcSEcCtD
Meloxicam—Vision blurred—Carmustine—melanoma	0.000242	0.0019	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Docetaxel—melanoma	0.000241	0.00189	CcSEcCtD
Meloxicam—Tremor—Carmustine—melanoma	0.00024	0.00189	CcSEcCtD
Meloxicam—Oedema—Bleomycin—melanoma	0.00024	0.00188	CcSEcCtD
Meloxicam—Anaphylactic shock—Bleomycin—melanoma	0.00024	0.00188	CcSEcCtD
Meloxicam—Back pain—Temozolomide—melanoma	0.00024	0.00188	CcSEcCtD
Meloxicam—Infection—Bleomycin—melanoma	0.000238	0.00187	CcSEcCtD
Meloxicam—Anaemia—Carmustine—melanoma	0.000237	0.00186	CcSEcCtD
Meloxicam—Nausea—Vemurafenib—melanoma	0.000235	0.00185	CcSEcCtD
Meloxicam—Thrombocytopenia—Bleomycin—melanoma	0.000235	0.00184	CcSEcCtD
Meloxicam—Vision blurred—Temozolomide—melanoma	0.000234	0.00183	CcSEcCtD
Meloxicam—Myalgia—Dactinomycin—melanoma	0.000233	0.00183	CcSEcCtD
Meloxicam—Bronchospasm—Docetaxel—melanoma	0.000233	0.00183	CcSEcCtD
Meloxicam—Tremor—Temozolomide—melanoma	0.000232	0.00182	CcSEcCtD
Meloxicam—Discomfort—Dactinomycin—melanoma	0.000231	0.00181	CcSEcCtD
Meloxicam—Angina pectoris—Docetaxel—melanoma	0.00023	0.00181	CcSEcCtD
Meloxicam—Ill-defined disorder—Temozolomide—melanoma	0.00023	0.0018	CcSEcCtD
Meloxicam—Leukopenia—Carmustine—melanoma	0.00023	0.0018	CcSEcCtD
Meloxicam—Anaemia—Temozolomide—melanoma	0.000229	0.0018	CcSEcCtD
Meloxicam—Angioedema—Temozolomide—melanoma	0.000227	0.00178	CcSEcCtD
Meloxicam—Pancytopenia—Docetaxel—melanoma	0.000225	0.00176	CcSEcCtD
Meloxicam—Hypotension—Bleomycin—melanoma	0.000224	0.00176	CcSEcCtD
Meloxicam—Oedema—Dactinomycin—melanoma	0.000224	0.00176	CcSEcCtD
Meloxicam—Malaise—Temozolomide—melanoma	0.000224	0.00175	CcSEcCtD
Meloxicam—Vertigo—Temozolomide—melanoma	0.000223	0.00175	CcSEcCtD
Meloxicam—Convulsion—Carmustine—melanoma	0.000222	0.00174	CcSEcCtD
Meloxicam—Infection—Dactinomycin—melanoma	0.000222	0.00174	CcSEcCtD
Meloxicam—Leukopenia—Temozolomide—melanoma	0.000222	0.00174	CcSEcCtD
Meloxicam—Hypertension—Carmustine—melanoma	0.000221	0.00174	CcSEcCtD
Meloxicam—Palpitations—Temozolomide—melanoma	0.000219	0.00172	CcSEcCtD
Meloxicam—Thrombocytopenia—Dactinomycin—melanoma	0.000219	0.00172	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Bleomycin—melanoma	0.000219	0.00171	CcSEcCtD
Meloxicam—Myalgia—Carmustine—melanoma	0.000218	0.00171	CcSEcCtD
Meloxicam—Anxiety—Carmustine—melanoma	0.000218	0.00171	CcSEcCtD
Meloxicam—Cough—Temozolomide—melanoma	0.000216	0.0017	CcSEcCtD
Meloxicam—Paraesthesia—Bleomycin—melanoma	0.000215	0.00169	CcSEcCtD
Meloxicam—Weight increased—Docetaxel—melanoma	0.000215	0.00169	CcSEcCtD
Meloxicam—Convulsion—Temozolomide—melanoma	0.000215	0.00169	CcSEcCtD
Meloxicam—Weight decreased—Docetaxel—melanoma	0.000214	0.00168	CcSEcCtD
Meloxicam—Hypertension—Temozolomide—melanoma	0.000214	0.00168	CcSEcCtD
Meloxicam—Dyspnoea—Bleomycin—melanoma	0.000214	0.00168	CcSEcCtD
Meloxicam—Confusional state—Carmustine—melanoma	0.000211	0.00166	CcSEcCtD
Meloxicam—Arthralgia—Temozolomide—melanoma	0.000211	0.00166	CcSEcCtD
Meloxicam—Myalgia—Temozolomide—melanoma	0.000211	0.00166	CcSEcCtD
Meloxicam—Infestation—Docetaxel—melanoma	0.000211	0.00166	CcSEcCtD
Meloxicam—Infestation NOS—Docetaxel—melanoma	0.000211	0.00166	CcSEcCtD
Meloxicam—Anxiety—Temozolomide—melanoma	0.00021	0.00165	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00021	0.00164	CcSEcCtD
Meloxicam—Oedema—Carmustine—melanoma	0.000209	0.00164	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000209	0.00164	CcSEcCtD
Meloxicam—Discomfort—Temozolomide—melanoma	0.000209	0.00164	CcSEcCtD
Meloxicam—Decreased appetite—Bleomycin—melanoma	0.000208	0.00164	CcSEcCtD
Meloxicam—Infection—Carmustine—melanoma	0.000208	0.00163	CcSEcCtD
Meloxicam—Acute coronary syndrome—Docetaxel—melanoma	0.000208	0.00163	CcSEcCtD
Meloxicam—Renal failure—Docetaxel—melanoma	0.000207	0.00163	CcSEcCtD
Meloxicam—ABCC4—lymph node—melanoma	0.000207	0.0162	CbGeAlD
Meloxicam—Myocardial infarction—Docetaxel—melanoma	0.000207	0.00162	CcSEcCtD
Meloxicam—Dry mouth—Temozolomide—melanoma	0.000206	0.00162	CcSEcCtD
Meloxicam—Stomatitis—Docetaxel—melanoma	0.000206	0.00161	CcSEcCtD
Meloxicam—Jaundice—Docetaxel—melanoma	0.000206	0.00161	CcSEcCtD
Meloxicam—Pain—Bleomycin—melanoma	0.000205	0.00161	CcSEcCtD
Meloxicam—Conjunctivitis—Docetaxel—melanoma	0.000205	0.00161	CcSEcCtD
Meloxicam—Thrombocytopenia—Carmustine—melanoma	0.000205	0.00161	CcSEcCtD
Meloxicam—Tachycardia—Carmustine—melanoma	0.000204	0.0016	CcSEcCtD
Meloxicam—Confusional state—Temozolomide—melanoma	0.000204	0.0016	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000204	0.0016	CcSEcCtD
Meloxicam—Anaphylactic shock—Temozolomide—melanoma	0.000202	0.00159	CcSEcCtD
Meloxicam—Oedema—Temozolomide—melanoma	0.000202	0.00159	CcSEcCtD
Meloxicam—Infection—Temozolomide—melanoma	0.000201	0.00158	CcSEcCtD
Meloxicam—Hepatobiliary disease—Docetaxel—melanoma	0.0002	0.00157	CcSEcCtD
Meloxicam—Nervous system disorder—Temozolomide—melanoma	0.000198	0.00156	CcSEcCtD
Meloxicam—Thrombocytopenia—Temozolomide—melanoma	0.000198	0.00155	CcSEcCtD
Meloxicam—Feeling abnormal—Bleomycin—melanoma	0.000198	0.00155	CcSEcCtD
Meloxicam—Agranulocytosis—Docetaxel—melanoma	0.000197	0.00154	CcSEcCtD
Meloxicam—Skin disorder—Temozolomide—melanoma	0.000197	0.00154	CcSEcCtD
Meloxicam—Hypotension—Carmustine—melanoma	0.000196	0.00153	CcSEcCtD
Meloxicam—Hyperhidrosis—Temozolomide—melanoma	0.000196	0.00153	CcSEcCtD
Meloxicam—Decreased appetite—Dactinomycin—melanoma	0.000194	0.00153	CcSEcCtD
Meloxicam—Fatigue—Dactinomycin—melanoma	0.000193	0.00151	CcSEcCtD
Meloxicam—Pain—Dactinomycin—melanoma	0.000191	0.0015	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Carmustine—melanoma	0.000191	0.0015	CcSEcCtD
Meloxicam—Urticaria—Bleomycin—melanoma	0.000191	0.0015	CcSEcCtD
Meloxicam—Haemoglobin—Docetaxel—melanoma	0.00019	0.00149	CcSEcCtD
Meloxicam—Rhinitis—Docetaxel—melanoma	0.00019	0.00149	CcSEcCtD
Meloxicam—Body temperature increased—Bleomycin—melanoma	0.00019	0.00149	CcSEcCtD
Meloxicam—Haemorrhage—Docetaxel—melanoma	0.000189	0.00149	CcSEcCtD
Meloxicam—Hepatitis—Docetaxel—melanoma	0.000189	0.00149	CcSEcCtD
Meloxicam—Insomnia—Carmustine—melanoma	0.000189	0.00149	CcSEcCtD
Meloxicam—Paraesthesia—Carmustine—melanoma	0.000188	0.00148	CcSEcCtD
Meloxicam—Pharyngitis—Docetaxel—melanoma	0.000188	0.00147	CcSEcCtD
Meloxicam—Urinary tract disorder—Docetaxel—melanoma	0.000187	0.00147	CcSEcCtD
Meloxicam—Dyspnoea—Carmustine—melanoma	0.000187	0.00146	CcSEcCtD
Meloxicam—Oedema peripheral—Docetaxel—melanoma	0.000187	0.00146	CcSEcCtD
Meloxicam—Somnolence—Carmustine—melanoma	0.000186	0.00146	CcSEcCtD
Meloxicam—Connective tissue disorder—Docetaxel—melanoma	0.000186	0.00146	CcSEcCtD
Meloxicam—Urethral disorder—Docetaxel—melanoma	0.000186	0.00146	CcSEcCtD
Meloxicam—Feeling abnormal—Dactinomycin—melanoma	0.000184	0.00145	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Temozolomide—melanoma	0.000184	0.00145	CcSEcCtD
Meloxicam—Insomnia—Temozolomide—melanoma	0.000183	0.00144	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dactinomycin—melanoma	0.000183	0.00144	CcSEcCtD
Meloxicam—Visual impairment—Docetaxel—melanoma	0.000183	0.00143	CcSEcCtD
Meloxicam—Decreased appetite—Carmustine—melanoma	0.000182	0.00143	CcSEcCtD
Meloxicam—Paraesthesia—Temozolomide—melanoma	0.000182	0.00143	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Carmustine—melanoma	0.000181	0.00142	CcSEcCtD
Meloxicam—Dyspnoea—Temozolomide—melanoma	0.00018	0.00142	CcSEcCtD
Meloxicam—Somnolence—Temozolomide—melanoma	0.00018	0.00141	CcSEcCtD
Meloxicam—Erythema multiforme—Docetaxel—melanoma	0.000179	0.0014	CcSEcCtD
Meloxicam—Pain—Carmustine—melanoma	0.000179	0.0014	CcSEcCtD
Meloxicam—Constipation—Carmustine—melanoma	0.000179	0.0014	CcSEcCtD
Meloxicam—Dyspepsia—Temozolomide—melanoma	0.000178	0.0014	CcSEcCtD
Meloxicam—Eye disorder—Docetaxel—melanoma	0.000177	0.00139	CcSEcCtD
Meloxicam—Body temperature increased—Dactinomycin—melanoma	0.000177	0.00139	CcSEcCtD
Meloxicam—Abdominal pain—Dactinomycin—melanoma	0.000177	0.00139	CcSEcCtD
Meloxicam—Hypersensitivity—Bleomycin—melanoma	0.000177	0.00139	CcSEcCtD
Meloxicam—Decreased appetite—Temozolomide—melanoma	0.000176	0.00138	CcSEcCtD
Meloxicam—Cardiac disorder—Docetaxel—melanoma	0.000176	0.00138	CcSEcCtD
Meloxicam—Flushing—Docetaxel—melanoma	0.000176	0.00138	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Temozolomide—melanoma	0.000175	0.00137	CcSEcCtD
Meloxicam—Fatigue—Temozolomide—melanoma	0.000174	0.00137	CcSEcCtD
Meloxicam—PTGS1—head—melanoma	0.000174	0.0136	CbGeAlD
Meloxicam—Pain—Temozolomide—melanoma	0.000173	0.00136	CcSEcCtD
Meloxicam—Constipation—Temozolomide—melanoma	0.000173	0.00136	CcSEcCtD
Meloxicam—Feeling abnormal—Carmustine—melanoma	0.000173	0.00135	CcSEcCtD
Meloxicam—Asthenia—Bleomycin—melanoma	0.000172	0.00135	CcSEcCtD
Meloxicam—Angiopathy—Docetaxel—melanoma	0.000172	0.00135	CcSEcCtD
Meloxicam—Gastrointestinal pain—Carmustine—melanoma	0.000171	0.00134	CcSEcCtD
Meloxicam—Immune system disorder—Docetaxel—melanoma	0.000171	0.00134	CcSEcCtD
Meloxicam—Mediastinal disorder—Docetaxel—melanoma	0.000171	0.00134	CcSEcCtD
Meloxicam—Pruritus—Bleomycin—melanoma	0.00017	0.00133	CcSEcCtD
Meloxicam—Arrhythmia—Docetaxel—melanoma	0.000169	0.00133	CcSEcCtD
Meloxicam—Alopecia—Docetaxel—melanoma	0.000167	0.00131	CcSEcCtD
Meloxicam—Feeling abnormal—Temozolomide—melanoma	0.000167	0.00131	CcSEcCtD
Meloxicam—PTGS2—head—melanoma	0.000167	0.013	CbGeAlD
Meloxicam—Mental disorder—Docetaxel—melanoma	0.000166	0.0013	CcSEcCtD
Meloxicam—Abdominal pain—Carmustine—melanoma	0.000166	0.0013	CcSEcCtD
Meloxicam—Body temperature increased—Carmustine—melanoma	0.000166	0.0013	CcSEcCtD
Meloxicam—Gastrointestinal pain—Temozolomide—melanoma	0.000165	0.0013	CcSEcCtD
Meloxicam—Erythema—Docetaxel—melanoma	0.000165	0.00129	CcSEcCtD
Meloxicam—Malnutrition—Docetaxel—melanoma	0.000165	0.00129	CcSEcCtD
Meloxicam—Hypersensitivity—Dactinomycin—melanoma	0.000165	0.00129	CcSEcCtD
Meloxicam—Dysgeusia—Docetaxel—melanoma	0.000161	0.00127	CcSEcCtD
Meloxicam—Urticaria—Temozolomide—melanoma	0.000161	0.00126	CcSEcCtD
Meloxicam—Asthenia—Dactinomycin—melanoma	0.00016	0.00126	CcSEcCtD
Meloxicam—Abdominal pain—Temozolomide—melanoma	0.00016	0.00125	CcSEcCtD
Meloxicam—Body temperature increased—Temozolomide—melanoma	0.00016	0.00125	CcSEcCtD
Meloxicam—Back pain—Docetaxel—melanoma	0.000159	0.00125	CcSEcCtD
Meloxicam—Muscle spasms—Docetaxel—melanoma	0.000158	0.00124	CcSEcCtD
Meloxicam—Hypersensitivity—Carmustine—melanoma	0.000154	0.00121	CcSEcCtD
Meloxicam—Diarrhoea—Dactinomycin—melanoma	0.000153	0.0012	CcSEcCtD
Meloxicam—Vomiting—Bleomycin—melanoma	0.000152	0.0012	CcSEcCtD
Meloxicam—Anaemia—Docetaxel—melanoma	0.000152	0.0012	CcSEcCtD
Meloxicam—Rash—Bleomycin—melanoma	0.000151	0.00119	CcSEcCtD
Meloxicam—Dermatitis—Bleomycin—melanoma	0.000151	0.00119	CcSEcCtD
Meloxicam—Asthenia—Carmustine—melanoma	0.00015	0.00118	CcSEcCtD
Meloxicam—Hypersensitivity—Temozolomide—melanoma	0.000149	0.00117	CcSEcCtD
Meloxicam—Syncope—Docetaxel—melanoma	0.000148	0.00116	CcSEcCtD
Meloxicam—Leukopenia—Docetaxel—melanoma	0.000148	0.00116	CcSEcCtD
Meloxicam—Palpitations—Docetaxel—melanoma	0.000146	0.00114	CcSEcCtD
Meloxicam—Asthenia—Temozolomide—melanoma	0.000145	0.00114	CcSEcCtD
Meloxicam—Loss of consciousness—Docetaxel—melanoma	0.000145	0.00114	CcSEcCtD
Meloxicam—Cough—Docetaxel—melanoma	0.000144	0.00113	CcSEcCtD
Meloxicam—Diarrhoea—Carmustine—melanoma	0.000143	0.00112	CcSEcCtD
Meloxicam—Pruritus—Temozolomide—melanoma	0.000143	0.00112	CcSEcCtD
Meloxicam—Convulsion—Docetaxel—melanoma	0.000143	0.00112	CcSEcCtD
Meloxicam—Nausea—Bleomycin—melanoma	0.000142	0.00112	CcSEcCtD
Meloxicam—Hypertension—Docetaxel—melanoma	0.000142	0.00112	CcSEcCtD
Meloxicam—Vomiting—Dactinomycin—melanoma	0.000142	0.00112	CcSEcCtD
Meloxicam—Rash—Dactinomycin—melanoma	0.000141	0.00111	CcSEcCtD
Meloxicam—Arthralgia—Docetaxel—melanoma	0.00014	0.0011	CcSEcCtD
Meloxicam—Myalgia—Docetaxel—melanoma	0.00014	0.0011	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000139	0.00109	CcSEcCtD
Meloxicam—Dizziness—Carmustine—melanoma	0.000138	0.00109	CcSEcCtD
Meloxicam—Diarrhoea—Temozolomide—melanoma	0.000138	0.00109	CcSEcCtD
Meloxicam—Dry mouth—Docetaxel—melanoma	0.000137	0.00108	CcSEcCtD
Meloxicam—Confusional state—Docetaxel—melanoma	0.000136	0.00106	CcSEcCtD
Meloxicam—Anaphylactic shock—Docetaxel—melanoma	0.000135	0.00106	CcSEcCtD
Meloxicam—Oedema—Docetaxel—melanoma	0.000135	0.00106	CcSEcCtD
Meloxicam—Dizziness—Temozolomide—melanoma	0.000134	0.00105	CcSEcCtD
Meloxicam—Infection—Docetaxel—melanoma	0.000134	0.00105	CcSEcCtD
Meloxicam—Vomiting—Carmustine—melanoma	0.000133	0.00104	CcSEcCtD
Meloxicam—Nausea—Dactinomycin—melanoma	0.000133	0.00104	CcSEcCtD
Meloxicam—Shock—Docetaxel—melanoma	0.000132	0.00104	CcSEcCtD
Meloxicam—Rash—Carmustine—melanoma	0.000132	0.00104	CcSEcCtD
Meloxicam—Nervous system disorder—Docetaxel—melanoma	0.000132	0.00104	CcSEcCtD
Meloxicam—Dermatitis—Carmustine—melanoma	0.000132	0.00103	CcSEcCtD
Meloxicam—Thrombocytopenia—Docetaxel—melanoma	0.000132	0.00103	CcSEcCtD
Meloxicam—Tachycardia—Docetaxel—melanoma	0.000131	0.00103	CcSEcCtD
Meloxicam—Headache—Carmustine—melanoma	0.000131	0.00103	CcSEcCtD
Meloxicam—Skin disorder—Docetaxel—melanoma	0.000131	0.00103	CcSEcCtD
Meloxicam—Vomiting—Temozolomide—melanoma	0.000129	0.00101	CcSEcCtD
Meloxicam—Rash—Temozolomide—melanoma	0.000128	0.001	CcSEcCtD
Meloxicam—Dermatitis—Temozolomide—melanoma	0.000127	0.001	CcSEcCtD
Meloxicam—Headache—Temozolomide—melanoma	0.000127	0.000994	CcSEcCtD
Meloxicam—Hypotension—Docetaxel—melanoma	0.000126	0.000986	CcSEcCtD
Meloxicam—Nausea—Carmustine—melanoma	0.000124	0.000976	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Docetaxel—melanoma	0.000123	0.000962	CcSEcCtD
Meloxicam—PTGS1—lymph node—melanoma	0.000122	0.00951	CbGeAlD
Meloxicam—Insomnia—Docetaxel—melanoma	0.000122	0.000955	CcSEcCtD
Meloxicam—Paraesthesia—Docetaxel—melanoma	0.000121	0.000948	CcSEcCtD
Meloxicam—Nausea—Temozolomide—melanoma	0.00012	0.000943	CcSEcCtD
Meloxicam—Dyspnoea—Docetaxel—melanoma	0.00012	0.000941	CcSEcCtD
Meloxicam—Somnolence—Docetaxel—melanoma	0.00012	0.000939	CcSEcCtD
Meloxicam—Dyspepsia—Docetaxel—melanoma	0.000118	0.000929	CcSEcCtD
Meloxicam—Decreased appetite—Docetaxel—melanoma	0.000117	0.000918	CcSEcCtD
Meloxicam—PTGS2—lymph node—melanoma	0.000117	0.00909	CbGeAlD
Meloxicam—Gastrointestinal disorder—Docetaxel—melanoma	0.000116	0.000911	CcSEcCtD
Meloxicam—Fatigue—Docetaxel—melanoma	0.000116	0.00091	CcSEcCtD
Meloxicam—Pain—Docetaxel—melanoma	0.000115	0.000903	CcSEcCtD
Meloxicam—Constipation—Docetaxel—melanoma	0.000115	0.000903	CcSEcCtD
Meloxicam—Feeling abnormal—Docetaxel—melanoma	0.000111	0.00087	CcSEcCtD
Meloxicam—Gastrointestinal pain—Docetaxel—melanoma	0.00011	0.000863	CcSEcCtD
Meloxicam—Body temperature increased—Docetaxel—melanoma	0.000106	0.000835	CcSEcCtD
Meloxicam—Abdominal pain—Docetaxel—melanoma	0.000106	0.000835	CcSEcCtD
Meloxicam—Hypersensitivity—Docetaxel—melanoma	9.91e-05	0.000778	CcSEcCtD
Meloxicam—Asthenia—Docetaxel—melanoma	9.65e-05	0.000757	CcSEcCtD
Meloxicam—Pruritus—Docetaxel—melanoma	9.52e-05	0.000747	CcSEcCtD
Meloxicam—Diarrhoea—Docetaxel—melanoma	9.21e-05	0.000722	CcSEcCtD
Meloxicam—Dizziness—Docetaxel—melanoma	8.9e-05	0.000698	CcSEcCtD
Meloxicam—Vomiting—Docetaxel—melanoma	8.55e-05	0.000671	CcSEcCtD
Meloxicam—Rash—Docetaxel—melanoma	8.48e-05	0.000666	CcSEcCtD
Meloxicam—Dermatitis—Docetaxel—melanoma	8.48e-05	0.000665	CcSEcCtD
Meloxicam—Headache—Docetaxel—melanoma	8.43e-05	0.000661	CcSEcCtD
Meloxicam—Nausea—Docetaxel—melanoma	7.99e-05	0.000627	CcSEcCtD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.8e-05	0.000294	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTEN—melanoma	1.8e-05	0.000294	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.79e-05	0.000292	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—melanoma	1.79e-05	0.000291	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NPPA—melanoma	1.76e-05	0.000286	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.75e-05	0.000286	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.75e-05	0.000286	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK1—melanoma	1.75e-05	0.000285	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—melanoma	1.75e-05	0.000285	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ACER3—melanoma	1.74e-05	0.000283	CbGpPWpGaD
Meloxicam—PTGS2—Disease—VCAN—melanoma	1.71e-05	0.00028	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.71e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS2—Disease—WNT5A—melanoma	1.7e-05	0.000277	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PHGDH—melanoma	1.7e-05	0.000277	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LUM—melanoma	1.7e-05	0.000277	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLCB4—melanoma	1.7e-05	0.000277	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.67e-05	0.000272	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HPSE—melanoma	1.67e-05	0.000272	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	1.67e-05	0.000272	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.66e-05	0.00027	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.65e-05	0.00027	CbGpPWpGaD
Meloxicam—PGD—Disease—KRAS—melanoma	1.65e-05	0.000269	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CUBN—melanoma	1.64e-05	0.000267	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PLA2G6—melanoma	1.6e-05	0.000261	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—melanoma	1.6e-05	0.00026	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC6A11—melanoma	1.6e-05	0.00026	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIP4K2A—melanoma	1.6e-05	0.00026	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UGT2B10—melanoma	1.59e-05	0.000259	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SDHD—melanoma	1.58e-05	0.000258	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BSG—melanoma	1.58e-05	0.000258	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CSPG4—melanoma	1.58e-05	0.000258	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NRAS—melanoma	1.58e-05	0.000257	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTAP—melanoma	1.55e-05	0.000253	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPAM—melanoma	1.53e-05	0.000249	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP17A1—melanoma	1.53e-05	0.000249	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.52e-05	0.000248	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.52e-05	0.000247	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—melanoma	1.52e-05	0.000247	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK3—melanoma	1.51e-05	0.000246	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.51e-05	0.000245	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.49e-05	0.000242	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HS3ST5—melanoma	1.48e-05	0.000241	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.47e-05	0.00024	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GNA11—melanoma	1.44e-05	0.000235	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK1—melanoma	1.44e-05	0.000234	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—VCAN—melanoma	1.44e-05	0.000234	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—FASN—melanoma	1.41e-05	0.00023	CbGpPWpGaD
Meloxicam—PGD—Disease—HRAS—melanoma	1.4e-05	0.000229	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC5A5—melanoma	1.39e-05	0.000226	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LUM—melanoma	1.38e-05	0.000226	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PHGDH—melanoma	1.38e-05	0.000226	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GAB2—melanoma	1.37e-05	0.000223	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.36e-05	0.000222	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—KRAS—melanoma	1.36e-05	0.000221	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HPSE—melanoma	1.36e-05	0.000221	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—melanoma	1.34e-05	0.000219	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GNAQ—melanoma	1.34e-05	0.000219	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CD44—melanoma	1.34e-05	0.000219	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FASN—melanoma	1.34e-05	0.000218	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CUBN—melanoma	1.33e-05	0.000217	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.31e-05	0.000214	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.31e-05	0.000214	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLA2G6—melanoma	1.3e-05	0.000212	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.3e-05	0.000212	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SDHD—melanoma	1.29e-05	0.00021	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BSG—melanoma	1.29e-05	0.00021	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CSPG4—melanoma	1.29e-05	0.00021	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1B1—melanoma	1.28e-05	0.000209	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FOXO4—melanoma	1.28e-05	0.000209	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CXCR4—melanoma	1.28e-05	0.000209	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HDAC2—melanoma	1.28e-05	0.000209	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD44—melanoma	1.27e-05	0.000207	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—melanoma	1.27e-05	0.000207	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—melanoma	1.25e-05	0.000203	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPAM—melanoma	1.25e-05	0.000203	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.24e-05	0.000203	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—melanoma	1.24e-05	0.000202	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP17A1—melanoma	1.21e-05	0.000198	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—melanoma	1.21e-05	0.000197	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.2e-05	0.000195	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.18e-05	0.000192	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT3—melanoma	1.17e-05	0.000191	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—VCAN—melanoma	1.17e-05	0.000191	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HRAS—melanoma	1.15e-05	0.000188	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GNA11—melanoma	1.14e-05	0.000187	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.13e-05	0.000185	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—FASN—melanoma	1.12e-05	0.000183	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLCB4—melanoma	1.12e-05	0.000182	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.11e-05	0.00018	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC5A5—melanoma	1.1e-05	0.00018	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.07e-05	0.000174	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GNAQ—melanoma	1.06e-05	0.000173	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CD44—melanoma	1.06e-05	0.000173	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLA2G6—melanoma	1.06e-05	0.000173	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCB1—melanoma	1.06e-05	0.000173	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIP4K2A—melanoma	1.05e-05	0.000172	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC6A11—melanoma	1.05e-05	0.000172	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.04e-05	0.00017	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—melanoma	1.04e-05	0.000169	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB4—melanoma	1.04e-05	0.000169	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN2B—melanoma	1.03e-05	0.000167	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTAP—melanoma	1.02e-05	0.000167	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1B1—melanoma	1.02e-05	0.000166	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—melanoma	1.02e-05	0.000166	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD86—melanoma	9.93e-06	0.000162	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP17A1—melanoma	9.86e-06	0.000161	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PRKCA—melanoma	9.74e-06	0.000159	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.72e-06	0.000159	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ERCC2—melanoma	9.66e-06	0.000157	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FGF1—melanoma	9.63e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	9.6e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—VCAN—melanoma	9.51e-06	0.000155	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PDGFRA—melanoma	9.32e-06	0.000152	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GNA11—melanoma	9.31e-06	0.000152	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PRKCA—melanoma	9.23e-06	0.00015	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERCC2—melanoma	9.15e-06	0.000149	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LUM—melanoma	9.12e-06	0.000149	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PHGDH—melanoma	9.12e-06	0.000149	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—FASN—melanoma	9.11e-06	0.000149	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAP2K2—melanoma	9.02e-06	0.000147	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9e-06	0.000147	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	9e-06	0.000147	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC5A5—melanoma	8.96e-06	0.000146	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HPSE—melanoma	8.94e-06	0.000146	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CUBN—melanoma	8.78e-06	0.000143	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.69e-06	0.000142	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GNAQ—melanoma	8.66e-06	0.000141	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CD44—melanoma	8.66e-06	0.000141	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TERT—melanoma	8.58e-06	0.00014	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HLA-A—melanoma	8.58e-06	0.00014	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RAC1—melanoma	8.56e-06	0.00014	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SDHD—melanoma	8.48e-06	0.000138	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BSG—melanoma	8.48e-06	0.000138	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CSPG4—melanoma	8.48e-06	0.000138	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.48e-06	0.000138	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCB1—melanoma	8.4e-06	0.000137	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.4e-06	0.000137	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1B1—melanoma	8.3e-06	0.000135	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPAM—melanoma	8.21e-06	0.000134	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIF1A—melanoma	8.21e-06	0.000134	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP17A1—melanoma	8.02e-06	0.000131	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8e-06	0.00013	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.91e-06	0.000129	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	7.81e-06	0.000127	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PRKCA—melanoma	7.73e-06	0.000126	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ERCC2—melanoma	7.67e-06	0.000125	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CG—melanoma	7.63e-06	0.000124	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GNA11—melanoma	7.58e-06	0.000124	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—melanoma	7.46e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FASN—melanoma	7.42e-06	0.000121	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOTCH1—melanoma	7.39e-06	0.000121	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—melanoma	7.36e-06	0.00012	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.32e-06	0.000119	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC5A5—melanoma	7.29e-06	0.000119	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD80—melanoma	7.24e-06	0.000118	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KIT—melanoma	7.23e-06	0.000118	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—melanoma	7.23e-06	0.000118	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGF—melanoma	7.15e-06	0.000117	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GNAQ—melanoma	7.04e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CD44—melanoma	7.04e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLA2G6—melanoma	6.98e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.9e-06	0.000112	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.83e-06	0.000111	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCB1—melanoma	6.83e-06	0.000111	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BRAF—melanoma	6.79e-06	0.000111	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1B1—melanoma	6.75e-06	0.00011	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CD—melanoma	6.7e-06	0.000109	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—melanoma	6.62e-06	0.000108	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAP2K1—melanoma	6.4e-06	0.000104	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CD—melanoma	6.35e-06	0.000104	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.35e-06	0.000104	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PRKCA—melanoma	6.29e-06	0.000103	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—VCAN—melanoma	6.27e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ERCC2—melanoma	6.24e-06	0.000102	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FGF2—melanoma	6.08e-06	9.92e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CG—melanoma	6.05e-06	9.87e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.96e-06	9.72e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CB—melanoma	5.84e-06	9.53e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—melanoma	5.84e-06	9.53e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—melanoma	5.79e-06	9.44e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MDM2—melanoma	5.69e-06	9.28e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB2—melanoma	5.61e-06	9.15e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCB1—melanoma	5.56e-06	9.07e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CB—melanoma	5.54e-06	9.03e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD4—melanoma	5.53e-06	9.02e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CD—melanoma	5.32e-06	8.68e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP17A1—melanoma	5.29e-06	8.63e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—melanoma	5.25e-06	8.57e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1B—melanoma	5.2e-06	8.48e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.17e-06	8.43e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PRKCA—melanoma	5.12e-06	8.35e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ERCC2—melanoma	5.08e-06	8.28e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTEN—melanoma	5.05e-06	8.23e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GNA11—melanoma	5e-06	8.15e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CG—melanoma	4.93e-06	8.03e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CTNNB1—melanoma	4.91e-06	8.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FASN—melanoma	4.89e-06	7.97e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC5A5—melanoma	4.81e-06	7.84e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1A—melanoma	4.8e-06	7.82e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PTEN—melanoma	4.79e-06	7.81e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—melanoma	4.75e-06	7.75e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GNAQ—melanoma	4.65e-06	7.58e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CD44—melanoma	4.65e-06	7.58e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CB—melanoma	4.64e-06	7.56e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1B1—melanoma	4.45e-06	7.26e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CD—melanoma	4.33e-06	7.06e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—melanoma	4.28e-06	6.98e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—melanoma	4.27e-06	6.97e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NRAS—melanoma	4.27e-06	6.96e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.2e-06	6.86e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK3—melanoma	4.09e-06	6.67e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CG—melanoma	4.01e-06	6.54e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTEN—melanoma	4.01e-06	6.54e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—melanoma	3.98e-06	6.49e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK1—melanoma	3.89e-06	6.35e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—melanoma	3.89e-06	6.34e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—melanoma	3.87e-06	6.31e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CB—melanoma	3.77e-06	6.16e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—melanoma	3.74e-06	6.1e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KRAS—melanoma	3.68e-06	5.99e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCB1—melanoma	3.67e-06	5.98e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—melanoma	3.56e-06	5.81e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CD—melanoma	3.52e-06	5.75e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—melanoma	3.48e-06	5.67e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—melanoma	3.38e-06	5.51e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PRKCA—melanoma	3.38e-06	5.5e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ERCC2—melanoma	3.35e-06	5.46e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTEN—melanoma	3.26e-06	5.32e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HRAS—melanoma	3.12e-06	5.09e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CB—melanoma	3.07e-06	5.01e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—melanoma	3.04e-06	4.96e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—melanoma	2.99e-06	4.88e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—melanoma	2.91e-06	4.75e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—melanoma	2.83e-06	4.61e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—melanoma	2.76e-06	4.5e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTEN—melanoma	2.65e-06	4.33e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CG—melanoma	2.64e-06	4.31e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—melanoma	2.55e-06	4.16e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CD—melanoma	2.32e-06	3.79e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—melanoma	2.31e-06	3.77e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—melanoma	2.3e-06	3.75e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—melanoma	2.29e-06	3.74e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CB—melanoma	2.03e-06	3.3e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—melanoma	2.01e-06	3.27e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—melanoma	1.88e-06	3.07e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—melanoma	1.87e-06	3.05e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTEN—melanoma	1.75e-06	2.85e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—melanoma	1.53e-06	2.49e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—melanoma	1.24e-06	2.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—melanoma	1.01e-06	1.65e-05	CbGpPWpGaD
